Understanding the Need for Alternatives to GLP-1 RAs
As GLP-1 receptor agonists (GLP-1 RAs) like semaglutide and tirzepatide become increasingly popular for weight management, concerns around long-term tolerability and side effects continue to rise. While these injectables mimic the gut hormone GLP-1 to help manage appetite, they often cause gastrointestinal issues and systemic side effects that can lead to poor adherence1.
The Side Effects of GLP-1 Injectables
Commonly reported issues with GLP-1 RAs include nausea, vomiting, diarrhea, and constipation2,3. More severe complications like pancreatitis and bowel obstruction have also been observed4. Reports suggest additional risks such as mood changes, alopecia, and even eye-related conditions like age-related macular degeneration5,6,7.
How Calocurb Works
Calocurb® offers a natural alternative by supporting your body's own GLP-1 production. Its key ingredient, Amarasate® (a bitter hops extract), is delivered to the small intestine using delayed-release capsules. There, it stimulates bitter taste receptors, prompting your body to naturally increase satiety hormones like GLP-1 and CCK, which help reduce calorie intake8,9.
Clinical Research on Calocurb
In clinical trials, Calocurb doubled post-meal GLP-1 levels and significantly reduced food intake by 18%8. During fasting studies, women experienced a 30% reduction in hunger and a 40% decrease in cravings, while men reported 25% lower hunger scores10,11.
What About Side Effects?
Unlike injectables, Calocurb is well tolerated. Loose stools were reported in just 5–10% of users, typically during early use and often manageable with gradual dose escalation9,10. Mild heartburn may occur, but no serious adverse effects have been reported in over five years of commercial use.
A Physiological Advantage
Calocurb supports your body's natural rhythms. Rather than maintaining unnaturally high hormone levels like injectables do, Calocurb stimulates GLP-1 for 4–6 hours post-dose—more in line with how your body works. It has minimal systemic absorption, focusing its action within the gut.
Professional Endorsement
Healthcare professionals across various disciplines—from integrative doctors to dietitians—endorse Calocurb. Some even use it alongside GLP-1 RAs to reduce injectable dosages while preserving results.
Final Thoughts
With a strong safety record and proven appetite-regulating effects, Calocurb provides a compelling option for those seeking a natural, well-tolerated solution—either as a standalone or complementary approach to GLP-1 therapies.
References
- Rodriguez PJ, Zhang V, Gratzl S, et al. JAMA Netw Open. 2025;8(1):e2457349.
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. NEJM. 2022;387(3).
- Wilding JPH, Batterham RL, Calanna S, et al. NEJM. 2021;384(11):989-1002.
- Sodhi M, Rezaeianzadeh R, Kezouh A, Etminan M. JAMA. 2023;330(18).
- Wang W, Volkow ND, Berger NA, et al. Nat Med. 2024;30(1):168-176.
- Schoretsanitis G, Weiler S, Barbui C, et al. JAMA Netw Open. 2024;7(8):e2423385.
- Shor R, Mihalache A, Noori A, et al. JAMA Ophthalmol. 2025.
- Walker EG, Lo KR, Pahl MC, et al. Am J Clin Nutr. 2022;115(3):925-940.
- Lim JJ, Poppitt SD. Nutrients. 2019;11(7):1517.
- Walker E, Lo K, Gopal P. Obes Pillars. 2024;11:100117.
- Walker E, Lo K, Tham S, et al. Nutrients. 2019;11(11):2754.